Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Osteoporosis risk assessment and ethnicity: validation and comparison of 2 clinical risk stratification instruments.

Cass AR, Shepherd AJ, Carlson CA.

J Gen Intern Med. 2006 Jun;21(6):630-5.

PMID:
16808748
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke.

Sato Y, Iwamoto J, Kanoko T, Satoh K.

Arch Intern Med. 2005 Aug 8-22;165(15):1743-8.

PMID:
16087822
[PubMed - indexed for MEDLINE]
3.

Development of a clinical assessment tool in identifying Asian men with low bone mineral density and comparison of its usefulness to quantitative bone ultrasound.

Kung AW, Ho AY, Ross PD, Reginster JY.

Osteoporos Int. 2005 Jul;16(7):849-55. Epub 2004 Dec 21.

PMID:
15611839
[PubMed - indexed for MEDLINE]
4.

Risk assessment and screening for low bone mineral density in a multi-ethnic population of women and men: does one approach fit all?

Broussard DL, Magnus JH.

Osteoporos Int. 2004 May;15(5):349-60. Epub 2003 Dec 16. Review.

PMID:
14676991
[PubMed - indexed for MEDLINE]
5.

Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study.

Gonnelli S, Cepollaro C, Montagnani A, Bruni D, Caffarelli C, Breschi M, Gennari L, Gennari C, Nuti R.

Calcif Tissue Int. 2003 Aug;73(2):133-9.

PMID:
14565594
[PubMed - indexed for MEDLINE]
6.

Performance of the Osteoporosis Self-assessment Screening Tool for osteoporosis in American men.

Adler RA, Tran MT, Petkov VI.

Mayo Clin Proc. 2003 Jun;78(6):723-7.

PMID:
12934782
[PubMed - indexed for MEDLINE]
7.

2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Brown JP, Josse RG; Scientific Advisory Council of the Osteoporosis Society of Canada.

CMAJ. 2002 Nov 12;167(10 Suppl):S1-34. Review. Erratum in: CMAJ. 2003 Mar 18;168(6):676.. CMAJ. 2003 Mar 4;168(5):544. CMAJ. 2003 Feb 18;168(4):400.

PMID:
12427685
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force.

Nelson HD, Helfand M, Woolf SH, Allan JD.

Ann Intern Med. 2002 Sep 17;137(6):529-41.

PMID:
12230356
[PubMed - indexed for MEDLINE]
9.

Can family history be used as a tool for public health and preventive medicine?

Yoon PW, Scheuner MT, Peterson-Oehlke KL, Gwinn M, Faucett A, Khoury MJ.

Genet Med. 2002 Jul-Aug;4(4):304-10. No abstract available.

PMID:
12172397
[PubMed - indexed for MEDLINE]
10.

Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.

Hodsman AB, Hanley DA, Josse R.

CMAJ. 2002 May 28;166(11):1426-30. No abstract available.

PMID:
12054412
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A simple tool to identify asian women at increased risk of osteoporosis.

Koh LK, Sedrine WB, Torralba TP, Kung A, Fujiwara S, Chan SP, Huang QR, Rajatanavin R, Tsai KS, Park HM, Reginster JY; Osteoporosis Self-Assessment Tool for Asians (OSTA) Research Group.

Osteoporos Int. 2001;12(8):699-705.

PMID:
11580084
[PubMed - indexed for MEDLINE]
12.

The burden of osteoporotic fractures: a method for setting intervention thresholds.

Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A.

Osteoporos Int. 2001;12(5):417-27.

PMID:
11444092
[PubMed - indexed for MEDLINE]
13.

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY; Hip Intervention Program Study Group.

N Engl J Med. 2001 Feb 1;344(5):333-40.

PMID:
11172164
[PubMed - indexed for MEDLINE]
Free Article
14.

Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group.

Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR; Fracture Intervention Trial.

J Clin Endocrinol Metab. 2000 Nov;85(11):4118-24. Erratum in: J Clin Endocrinol Metab 2001 Feb;86(2):938.

PMID:
11095442
[PubMed - indexed for MEDLINE]
15.

Alendronate for the treatment of osteoporosis in men.

Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A.

N Engl J Med. 2000 Aug 31;343(9):604-10.

PMID:
10979796
[PubMed - indexed for MEDLINE]
Free Article
16.

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD.

JAMA. 1999 Oct 13;282(14):1344-52.

PMID:
10527181
[PubMed - indexed for MEDLINE]
17.

Survival after hip fracture: short- and long-term excess mortality according to age and gender.

Forsén L, Sogaard AJ, Meyer HE, Edna T, Kopjar B.

Osteoporos Int. 1999;10(1):73-8.

PMID:
10501783
[PubMed - indexed for MEDLINE]
18.

Secular trends in hip fracture occurrence and survival: age and sex differences.

Bacon WE.

J Aging Health. 1996 Nov;8(4):538-53.

PMID:
10182385
[PubMed - indexed for MEDLINE]
19.

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA.

Lancet. 1999 Mar 13;353(9156):878-82.

PMID:
10093980
[PubMed - indexed for MEDLINE]
20.

Updated data on proximal femur bone mineral levels of US adults.

Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay R.

Osteoporos Int. 1998;8(5):468-89.

PMID:
9850356
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk